Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
Eur J Rheumatol ; 2(4): 163-164, 2015 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27708956

RESUMEN

Scleredema is a rare connective tissue disorder of unknown pathogenesis. Three types of scleredema have been described, based on its association with postinfection, monoclonal gammopathy and diabetes mellitus. We report herein a case of scleredema which the diagnosis didn't get specified. The patient was followed regularly for 13 years and did not respond to various combinations of immunosuppressants and psoralen plus ultraviolet A therapy. Treatment of scleredema is quite difficult and of limited success. At present, there is no proved treatment for this disease.

3.
Rheumatol Int ; 32(5): 1215-8, 2012 May.
Artículo en Inglés | MEDLINE | ID: mdl-21258795

RESUMEN

Chronic interstitial cystitis (IC), mostly affecting middle-aged women, is a very rare manifestation of primary Sjögren's syndrome (pSS). Hereby, we report a 42-year-old woman with pSS, presenting with dysuria, urinary frequency, and suprapubic pain. She was diagnosed to have chronic IC, based upon the cystoscopic biopsy finding of chronic inflammation in the bladder wall. Systemic corticosteroid and azathioprine treatments together with local intravesical therapies were not effective. Therefore, cyclosporine (CSA) therapy was initiated. Initial low dose of CSA (1.5 mg/kg/d) improved the symptoms of the patient, with no requirement for dose increment. After 4 months of therapy, control cystoscopic biopsy showed that bladder inflammation regressed and IC improved. This case suggests that even low doses of CSA may be beneficial for treating chronic IC associated with pSS syndrome.


Asunto(s)
Ciclosporina/administración & dosificación , Cistitis Intersticial/tratamiento farmacológico , Inmunosupresores/administración & dosificación , Síndrome de Sjögren/tratamiento farmacológico , Adulto , Biopsia , Enfermedad Crónica , Cistitis Intersticial/diagnóstico , Cistitis Intersticial/etiología , Cistitis Intersticial/inmunología , Cistoscopía , Quimioterapia Combinada , Femenino , Humanos , Prednisona/administración & dosificación , Prednisona/análogos & derivados , Síndrome de Sjögren/complicaciones , Síndrome de Sjögren/diagnóstico , Síndrome de Sjögren/inmunología , Resultado del Tratamiento
4.
Rheumatol Int ; 32(6): 1675-8, 2012 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-21416236

RESUMEN

Familial Mediterranean fever (FMF) is the most common autoinflammatory disease characterized by recurrent self-limited attacks of fever, accompanied with peritonitis, pleuritis or arthritis. It is well known that FMF may coexist with vasculitic pathologies, especially with those involving small and medium vessels. Among the vasculitic pathologies reported to be associated with FMF, Henoch-Schönlein purpura and polyarteritis nodosa come the first, possibly followed up by protracted febrile myalgia. However, coexistence of FMF with any large vessel vasculitis has not been reported to date. Here, we present a case with FMF who later developed Takayasu arteritis, with a severe disease course, being resistant to corticosteroids and conventional immunosuppressive agents, and requiring infliximab treatment.


Asunto(s)
Fiebre Mediterránea Familiar/complicaciones , Arteritis de Takayasu/complicaciones , Corticoesteroides/uso terapéutico , Anticuerpos Monoclonales/uso terapéutico , Colchicina/uso terapéutico , Resistencia a Medicamentos , Fiebre Mediterránea Familiar/diagnóstico , Fiebre Mediterránea Familiar/tratamiento farmacológico , Fiebre Mediterránea Familiar/inmunología , Humanos , Inmunosupresores/uso terapéutico , Infliximab , Masculino , Índice de Severidad de la Enfermedad , Arteritis de Takayasu/diagnóstico , Arteritis de Takayasu/tratamiento farmacológico , Arteritis de Takayasu/inmunología , Insuficiencia del Tratamiento , Factor de Necrosis Tumoral alfa/antagonistas & inhibidores , Adulto Joven
5.
Rheumatol Int ; 30(11): 1483-7, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20358203

RESUMEN

A possible relationship between Takayasu arteritis (TA) and tuberculosis (TB) has been suggested. An increased frequency of tuberculin skin test (TST) was observed in TA patients. Quantiferon-TB Gold test (QFT) is a new in vitro assay measuring interferon-gamma response to M. tuberculosis antigens and helpful in diagnosing latent TB infection. The aim of this study was to investigate latent TB infection among TA patients by the use of both TST and QFT Gold test. Ninety-four (male/female: 7/87) TA patients fulfilling ACR 1990 TA criteria from three different university hospitals in Turkey and 107 control subjects without inflammatory diseases were included in the study. Data about medical history (TA and TB) were collected for both groups. TST and QFT were performed. TST values > or =5 mm for TA patients and > or =15 mm for controls was accepted as TST positivity. Even though TA group was older (40 +/- 12 vs. 32 +/- 8, P < 0.001), there was no significant difference between TA patients and controls regarding demographic characteristics. Six TA patients and one control had a history of previous TB infection (P = 0.054). Although TST positivity was higher in TA group [55 patients (62.5%) vs. 24 controls (41.4%), P = 0.008], QFT positivity was similar between two groups [21 patients (22.3%) vs. 24 controls (22.4%), P > 0.05]. QFT was negative in two of six TA patients with previous TB history. Rate of latent TB infection in TA patients measured with QFT is no more than controls. QFT seems to be a good and favorable test compared with TST in detecting LTBI in TA.


Asunto(s)
Tuberculosis Latente/diagnóstico , Arteritis de Takayasu/complicaciones , Arteritis de Takayasu/diagnóstico , Prueba de Tuberculina/métodos , Adolescente , Adulto , Niño , Preescolar , Comorbilidad , Femenino , Humanos , Lactante , Interferón gamma/sangre , Tuberculosis Latente/epidemiología , Masculino , Valor Predictivo de las Pruebas , Prevalencia , Sensibilidad y Especificidad , Prueba de Tuberculina/tendencias , Turquía , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...